Snowden Capital Advisors LLC Arcturus Therapeutics Holdings Inc. Transaction History

Snowden Capital Advisors LLC

  • $3.12 Billion
  • Q4 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$24.35 - $44.39 $12,978 - $23,659
533 Added 2.79%
19,660 $478,000
Q1 2024

May 15, 2024
BUY
$31.23 - $42.99 $234,287 - $322,510
7,502 Added 64.53%
19,127 $645,000
Q4 2023

Feb 14, 2024
BUY
$17.71 - $32.97 $39,812 - $74,116
2,248 Added 23.97%
11,625 $366,000
Q1 2023

May 15, 2023
SELL
$14.72 - $23.97 $95,518 - $155,541
-6,489 Reduced 40.9%
9,377 $224,000
Q3 2022

Nov 09, 2022
SELL
$13.05 - $22.13 $58,464 - $99,142
-4,480 Reduced 22.02%
15,866 $235,000
Q1 2022

May 16, 2022
BUY
$17.64 - $39.57 $46,834 - $105,058
2,655 Added 15.01%
20,346 $548,000
Q4 2021

Feb 14, 2022
BUY
$34.2 - $47.56 $605,032 - $841,383
17,691 New
17,691 $654,000
Q3 2021

Feb 05, 2024
BUY
$27.88 - $58.25 $631,147 - $1.32 Million
22,638 Added 241.42%
32,015 $1.53 Billion
Q2 2021

Jan 08, 2024
SELL
$25.79 - $42.11 $293,025 - $478,453
-11,362 Reduced 26.26%
31,909 $1.08 Billion
Q1 2021

Jan 08, 2024
BUY
$38.75 - $86.92 $516,460 - $1.16 Million
13,328 Added 44.51%
43,271 $1.79 Billion
Q4 2020

Jan 08, 2024
BUY
$34.61 - $123.66 $615,677 - $2.2 Million
17,789 Added 146.36%
29,943 $1.3 Billion
Q3 2020

Jan 08, 2024
BUY
$37.49 - $63.19 $104,109 - $175,478
2,777 Added 29.62%
12,154 $521 Million

Others Institutions Holding ARCT

# of Institutions
168
Shares Held
26M
Call Options Held
163K
Put Options Held
173K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $380M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email